{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:13:53Z","timestamp":1793578433173,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) is the leading cause of cervical cancers, causing 270.000 deaths annually worldwide of which 85% occur in developing countries with an increasing risk associated to HIV infection. This study aimed at comparing HPV\u2019s positivity and genotype distribution in women according to their HIV status and determinants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A comparative study was carried out in 2012 at the Chantal BIYA International Reference Centre (CIRCB) among 278 women enrolled consecutively at the General Hospital and the Gynaeco-Obstetric and Paediatric Hospital of the City of Yaound\u00e9. HPV genotyping was performed by real-time PCR, HIV serological screening by serial algorithm, CD4 T cell phenotyping by flow cytometry and HIV viral load by Abbott m2000RT. Statistical analyses were performed using Microsoft Excel 2016 and Graph Pad version 6.0 software; with\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05 considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Globally, mean age was 37\u2009\u00b1\u20093\u2009years; median CD4-count for HIV+ was 414 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      [IQR: 264.75\u2013588] and median viremia was 50 RNA copies\/mL [IQR: &lt;\u200940\u20138288]. Overall HPV rate was 38.49% (107\/278); 58.88% for single women vs. others (28.97% married, 2.80% divorced, 9.34% for widows), OR: 2.164;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0319. Following HIV status, HPV rate was 43.48% (80\/184) among HIV+ vs. 28.72% (27\/94) among HIV- (OR: 1.937;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0142); HPV genotypes among HIV+ vs. HIV- were respectively distributed as follows: genotype 16 (3.75% vs. 0.00%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.57), genotype 18 (3.75% vs. 3.70%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20091.00), co-infection 16 and others (8.75% vs. 7.40%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20091.00), co-infection 18 and others (8.75% vs. 11.11%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.71), co-infection 16, 18 and others (2.50% vs. 0.00%, p\u2009=\u20091.00) and other genotypes (72.50% vs. 77.78%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.80). Among HIV+ participants, HPV rate following CD4 was 62.88% (61\/97) for CD4\u2009&lt;\u2009500 vs. 35.71% (20\/56) for CD4\u2009\u2265\u2009500 (OR: 3.05;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0012) while HPV rate following HIV viremia was 42.71% (41\/96) with &lt;\u20091000 RNA copies\/ml vs. 66.00% (33\/50) with &gt;\u20091000 RNA copies\/ml (OR\u2009=\u20090.384;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In Yaound\u00e9, HPV rate appear to be very high, with higher rates of genotypes other than 16 and 18. In the event of HIV infection, the risk of HPV positivity is two times higher, favoured essentially by immunodeficiency. Thus, HIV-infected women should be closely monitored to prevent the emergence of cervical cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-020-01340-y","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T03:03:49Z","timestamp":1589857429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaound\u00e9, Cameroon"],"prefix":"10.1186","volume":"17","author":[{"given":"Samuel Martin","family":"Sosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Carlos Tommo","family":"Tchouaket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Fokam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Kamgaing","family":"Simo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Torimiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Tiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise Elong","family":"Lobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Ambada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Nange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezechiel Ngoufack Jagni","family":"Semengue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Durand","family":"Nka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e8re","family":"Tala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collins","family":"Chenwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aissatou","family":"Abba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude Christelle","family":"Ka\u2019e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouba","family":"Yagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Colizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ndjolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"issue":"2","key":"1340_CR1","first-page":"101","volume":"10","author":"SK Kjaer","year":"2001","unstructured":"Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomark. 2001;10(2):101\u20136.","journal-title":"Cancer Epidemiol Biomark"},{"issue":"4","key":"1340_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5301\/uro.5000101","volume":"81","author":"S Siracusano","year":"2014","unstructured":"Siracusano S, Silvestri T, Casotto D. Sexually transmitted diseases: epidemiological and clinical aspects in adults. Urologia. 2014;81(4):200\u20138.","journal-title":"Urologia"},{"issue":"11","key":"1340_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1340_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, de Sanjos\u00e9 S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789\u201399.","journal-title":"J Infect Dis"},{"issue":"5","key":"1340_CR5","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"key":"1340_CR6","doi-asserted-by":"publisher","unstructured":"Mathers CD, Loncar D. Projections of global mortalityand burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. https:\/\/doi.org\/10.1371\/journal.pmed.0030442.","DOI":"10.1371\/journal.pmed.0030442"},{"key":"1340_CR7","doi-asserted-by":"crossref","unstructured":"Am\u00e9gbor K, Darre T, Ay\u00e9na KD, Padaro E, Tengu\u00e9 K, Abalo A, et al. Cancers in Togo from 1984 to 2008: Epidemiological and Pathological Aspects of 5251 Cases. J Cancer Epidemiol. 2011:2011 Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3189592\/. [cit\u00e9 20 sept 2019].","DOI":"10.1155\/2011\/319872"},{"issue":"4","key":"1340_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.otc.2012.04.005","volume":"45","author":"SR Best","year":"2012","unstructured":"Best SR, Niparko KJ, Pai SI. Biology of HPV Infection and Immune Therapy for HPV-related Head and Neck Cancers. Otolaryngol Clin North Am. 2012;45(4):807\u201322 Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3398423\/. [cit\u00e9 20 mars 2020].","journal-title":"Otolaryngol Clin North Am"},{"issue":"12","key":"1340_CR9","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030\u201344.","journal-title":"Int J Cancer"},{"key":"1340_CR10","doi-asserted-by":"crossref","unstructured":"Verma M, Erwin S, Abedi V, Hontecillas R, Hoops S, Leber A, et al. Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa. PLoS ONE [Internet]. 2017;12(1). Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5218576\/. [cit\u00e9 20 mars 2020].","DOI":"10.1371\/journal.pone.0168133"},{"key":"1340_CR11","doi-asserted-by":"crossref","unstructured":"Ault KA. Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract. Infect Dis Obstet Gynecol. 2006:2006 Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1581465\/. [cit\u00e9 20 mars 2020].","DOI":"10.1155\/IDOG\/2006\/40470"},{"issue":"6","key":"1340_CR12","doi-asserted-by":"publisher","first-page":"e0217486","DOI":"10.1371\/journal.pone.0217486","volume":"14","author":"R-S Mboumba Bouassa","year":"2019","unstructured":"Mboumba Bouassa R-S, Nodjikouambaye ZA, Sadjoli D, Adawaye C, P\u00e9r\u00e9 H, Veyer D, et al. High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N\u2019Djamena, Chad. PLOS ONE. 2019;14(6):e0217486 Disponible sur: http:\/\/dx.plos.org\/10.1371\/journal.pone.0217486. [cit\u00e9 16 ao\u00fbt 2019].","journal-title":"PLOS ONE"},{"issue":"8","key":"1340_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/apm.12279","volume":"122","author":"E Lynge","year":"2014","unstructured":"Lynge E, Rygaard C, Baillet MV-P, Dugu\u00e9 P-A, Sander BB, Bonde J, et al. Cervical cancer screening at crossroads. APMIS. 2014;122(8):667\u201373 Disponible sur: http:\/\/doi.wiley.com\/10.1111\/apm.12279. [cit\u00e9 20 sept 2019].","journal-title":"APMIS"},{"key":"1340_CR14","unstructured":"Republic of Cameroon, Centre for the Development of Best Practices in Health. Epid\u00e9miological Profile of cancers in Cameroon. accessed at http:\/\/www.cdbph.org\/index.php\/base-de-connaissances-4\/9-publications-scientifiques\/584-profil-epidemiologique-du-cancer-au-cameroun."},{"key":"1340_CR15","doi-asserted-by":"publisher","unstructured":"Etienne L, Peeters M. Origine du VIH, Une r\u00e9ussite \u00e9mergentielle. Virologie. 2010;14(3):171\u201384. https:\/\/doi.org\/10.1684\/vir.2010.0307.","DOI":"10.1684\/vir.2010.0307"},{"issue":"5","key":"1340_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ajog.2014.12.003","volume":"212","author":"LS Massad","year":"2015","unstructured":"Massad LS, Xie X, D\u2019Souza G, Darragh TM, Minkoff H, Wright R, et al. Incidence of cervical precancers among HIV-seropositive women. Am J Obstet Gynecol. 2015;212(5):606 e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"5805","key":"1340_CR17","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1126\/science.1132338","volume":"314","author":"LJ Abu-Raddad","year":"2006","unstructured":"Abu-Raddad LJ, Patnaik P, Kublin JG. Dual Infection with HIV and Malaria Fuels the Spread of Both Diseases in Sub-Saharan Africa. Science. 2006;314(5805):1603\u20136. https:\/\/doi.org\/10.1126\/science.1132338.","journal-title":"Science"},{"key":"1340_CR18","first-page":"2015","volume":"16","author":"C Kabeyene Okono","year":"2015","unstructured":"Kabeyene Okono C, Descartes B, Mendimi Nkodo MJ, Sando Z, Anderson D, Amadou F, Essame Oyono JL. Serotypes of high risk human papi l loma virus among HIV infected women with cervical intra epithel ial lesions. Health Sci. 2015;16:2015.","journal-title":"Health Sci"},{"issue":"2","key":"1340_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00002030-199002000-00002","volume":"4","author":"J Albert","year":"1990","unstructured":"Albert J, Abrahamsson B, Nagy K, Aurelius E, Gaines H, Nystr\u00f6m G, et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS Lond Engl. 1990;4(2):107\u201312.","journal-title":"AIDS Lond Engl"},{"issue":"3","key":"1340_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/0956462413491735","volume":"25","author":"SA Denslow","year":"2014","unstructured":"Denslow SA, Rositch AF, Firnhaber C, Ting J, Smith JS. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS. 2014;25(3):163\u201377.","journal-title":"Int J STD AIDS"},{"key":"1340_CR21","unstructured":"Akom E, Venne S, Institut national de sant\u00e9 publique du Qu\u00e9bec. L\u2019infection au virus du papillome humain (VPH) [Internet]. Qu\u00e9bec: Institut national de sant\u00e9 publique du Qu\u00e9bec; 2003 [cit\u00e9 8 avr 2019]. Disponible sur: http:\/\/www.inspq.qc.ca\/publications\/defaultlien.asp?E=p&NumPublication=179&submit=1."},{"key":"1340_CR22","unstructured":"pubmeddev, al MN et. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. - PubMed - NCBI [Internet]. [cit\u00e9 22 sept 2019]. Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15197783."},{"issue":"2","key":"1340_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ijc.20244","volume":"111","author":"N Mu\u00f1oz","year":"2004","unstructured":"Mu\u00f1oz N, Bosch FX, Castellsagu\u00e9 X, D\u00edaz M, de Sanjose S, Hammouda D, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111(2):278\u201385.","journal-title":"Int J Cancer"},{"key":"1340_CR24","unstructured":"Gilbert Ndeh Doh, George Mondinde Ikomey, Duncan Njenda, Josiah Gichana, Mary Grace Katusiime, Valantine Ngum Ndze, Michelle Zeier, Martha Mesembe, Charles Fokunang, Marie Claire Okomo Assoumou, Pierre-Marie Tebeu, Paul Adrien Atangana, Graeme Brendon Jacobs. Oncogenic human papillomavirus genotypes 16 and 18 prevalence among women with normal cervical cytology and neoplasia in Cameroon: a systematic review. 2017."},{"issue":"4","key":"1340_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jcv.2004.08.009","volume":"32","author":"C Perrons","year":"2005","unstructured":"Perrons C, Jelley R, Kleter B, Quint W, Brink N. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10\/LiPA. J Clin Virol. 2005;32(4):278\u201385.","journal-title":"J Clin Virol"},{"issue":"5","key":"1340_CR26","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.ajog.2003.12.037","volume":"190","author":"LS Massad","year":"2004","unstructured":"Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, et al. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol. 2004;190(5):1241\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"1340_CR27","unstructured":"pubmeddev, al A-RC et. [Human papillomavirus genotype profile in Kinshasa, Democratic Republic of the Congo: implications for vaccination]. - PubMed - NCBI [Internet]. [cit\u00e9 22 sept 2019]. Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19639831."},{"key":"1340_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","volume":"31","author":"X Castellsagu\u00e9","year":"2003","unstructured":"Castellsagu\u00e9 X, Mu\u00f1oz N. Chapter 3: cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20\u20138.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"1340_CR29","doi-asserted-by":"crossref","unstructured":"Soto-De Leon S, Camargo M, Sanchez R, Munoz M, Perez-Prados A, Purroy A, et al. Distribution Patterns of Infection with Multiple Types of Human Papillomaviruses and Their Association with Risk Factors. PLoS ONE. 2011;6(2) Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3040737\/. [cit\u00e9 20 sept 2019].","DOI":"10.1371\/journal.pone.0014705"},{"issue":"3","key":"1340_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/QAI.0b013e3182676fe3","volume":"61","author":"JA Kahn","year":"2012","unstructured":"Kahn JA, Burk RD, Squires KE, Kapogiannis BG. Prevalence and Risk Factors for HPV in HIV-Positive Young Women Receiving Their First HPV Vaccination. JAIDS J Acquir Immune Defic Syndr. 2012;61(3):390\u20139.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"14","key":"1340_CR31","doi-asserted-by":"publisher","first-page":"e9545","DOI":"10.1097\/MD.0000000000009545","volume":"97","author":"RM Badial","year":"2018","unstructured":"Badial RM, Dias MC, Stuqui B, Melli PPDS. Detection and genotyping of human papillomavirus (HPV) in HIV-infected women and its relationship with HPV\/HIV co-infection. Medicine (Baltimore). 2018;97(14):e9545.","journal-title":"Medicine (Baltimore)"},{"key":"1340_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12879-014-0551-y","volume":"14","author":"X Castellsagu\u00e9","year":"2014","unstructured":"Castellsagu\u00e9 X, Paavonen J, Jaisamrarn U, Wheeler CM, Skinner SR, Lehtinen M, et al. Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial. BMC Infect Dis. 2014;14:551.","journal-title":"BMC Infect Dis"},{"key":"1340_CR33","doi-asserted-by":"publisher","unstructured":"Tian T, Mijiti P, Bingxue H, Fadong Z, Ainiwaer A, Guoyao S, Zhanlin Z, Mahan Y, Xiaoqin T, Zheng G, Jianghong D. Prevalence and risk factors of anal human papillomavirus infection among HIV-negative men who have sex with men in Urumqi city of Xinjiang Uyghur Autonomous Region, China. PLoS One. 2017;12(11):e0187928. https:\/\/doi.org\/10.1371\/journal.pone.0187928. eCollection 2017.","DOI":"10.1371\/journal.pone.0187928"},{"key":"1340_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1479-5876-7-108","volume":"7","author":"SH van der Burg","year":"2009","unstructured":"van der Burg SH, Palefsky JM. Human immunodeficiency virus and human papilloma virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med. 2009;7:108 Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2802355\/. [cit\u00e9 20 sept 2019].","journal-title":"J Transl Med"},{"issue":"6","key":"1340_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.7326\/0003-4819-138-6-200303180-00008","volume":"138","author":"C Piketty","year":"2003","unstructured":"Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med. 2003;138(6):453\u20139.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1340_CR36","first-page":"7629","volume":"14","author":"E Tartaglia","year":"2017","unstructured":"Tartaglia E, Falasca K, Vecchiet J, Sabusco GP, Picciano G, Di Marco R, et al. Prevalence of HPV infection among HIV-positive and HIV-negative women in Central\/Eastern Italy: Strategies of prevention. Oncol Lett. 2017;14(6):7629\u201335 Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5755221\/. [cit\u00e9 26 mars 2020].","journal-title":"Oncol Lett"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01340-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-020-01340-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01340-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T19:44:49Z","timestamp":1621367089000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-020-01340-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1186\/s12985-020-01340-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20286\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20286\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20286\/v2","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"2 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study obtained ethical clearance from the CIRCB Ethics Committee on the Project N<sup>0<\/sup> 1810 and also authorization from CIRCB where the study was conducted. The participants freely signed informed consent forms, which were written in French and English (with respect to the first language of the participant), while the minor participants provided their assent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that, this study is without conflicts of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}